组织陈列-产品详情

home > TISSUE ARRAYS > Liver > DLV8014

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

80

CASES:

67

Core Diameter(mm):

2

Thickness(µm):

5

Row number:

8

Column number:

10

Tissue Array Type:

FFPE

Species:

Human

DLV8014

$255.00

Description: Liver cancer, cirrhosis and liver tissue array, including pathology grade, TNM and clinical stage, 67 cases/80 cores

Details: Liver carcinoma, cirrhosis and liver tissue microarray, containing 48 cases of hepatocellular carcinoma, 5 cholangiocellular carcinoma, 22 cirrhosis (11 matched with cancer), 5 adjacent normal liver tissue (2 matched with cancer), single core per block

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

80 Cores 67 Cases Liver Matched or Unmatched special price Adjacent

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Cirrhosis(*)
NAT(*)
Malignant(IB)
Malignant(II)
Malignant(IIIA)
Malignant(IIIB)
Malignant(IVA)
_ma

TISSUE ARRAYS
DLV8014

	1	2	3	4	5	6	7	8	9	10
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

DLV8014

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Tumor size	Ki-67	CK18
A1	1	52	M	Liver	Hepatocellular carcinoma with necrosis	1	T3N0M0	IIIA	Malignant	1495.5	-	+,40%
A2	2	45	M	Liver	Hepatocellular carcinoma	1	T2N0M0	II	Malignant	5.04.04.0	-	++,90%
A3	3	41	M	Liver	Hepatocellular carcinoma	1	T2N0M0	II	Malignant	6.05.04.0	-	++,80%
A4	4	69	M	Liver	Hepatocellular carcinoma	1--2	T3aN0M0	IIIA	Malignant	1299	-	+,80%
A5	5	61	F	Liver	Hepatocellular carcinoma	2	T3N1M0	IVA	Malignant	7	-	+,70%
A6	6	72	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	5.55.03.5	-	++,100%
A7	7	49	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	1032.5	+,1%	++,90%
A8	8	43	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	*	+,5%	+++,100%
A9	9	40	M	Liver	Hepatocellular carcinoma	2	T3N1M0	IVA	Malignant	5	+,5%	++,90%
A10	10	77	M	Liver	Hepatocellular carcinoma with necrosis	2	T3aN0M0	IIIA	Malignant	6.05.05.0	-	+,60%
B1	11	63	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	4.03.52.5	-	++,40%
B2	12	51	M	Liver	Hepatocellular carcinoma	2	T3aN1M0	IVA	Malignant	6	-	+,70%
B3	13	56	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	644	-	++,90%
B4	14	45	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	4.54.03.0	+,15%	+,60%
B5	15	53	F	Liver	Hepatocellular carcinoma	2	T1bN0M0	IB	Malignant	643	-	+++,90%
B6	16	37	M	Liver	Hepatocellular carcinoma with necrosis	2	T3N0M0	IIIA	Malignant	4.54.03.5	+,10%	+,60%
B7	17	60	M	Liver	Hepatocellular carcinoma	2	T3aN0M0	IIIA	Malignant	6.55.03.5	+,3%	++,90%
B8	18	49	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	422	-	+,20%
B9	19	45	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	4.53.03.0	-	++,90%
B10	20	57	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	6.55.03.5	+,3%	+++,100%
C1	21	32	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	543	-	++,80%
C2	22	62	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	6.04.03.0	+,1%	++,90%
C3	23	36	F	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	*	+,5%	++,80%
C4	24	63	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	*	+,1%	+,40%
C5	25	48	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	654	-	++,90%
C6	26	62	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	753	+,15%	+,40%
C7	27	74	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	6*5	+,2%	+,20%
C8	28	50	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	4*3	-	++,80%
C9	29	24	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	542.5	-	+++,100%
C10	30	58	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	776	-	++,90%
D1	31	63	F	Liver	Hepatocellular carcinoma with necrosis	2	T3N0M0	IIIA	Malignant	7	+,10%	++,70%
D2	32	51	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	3.5	-	+,30%
D3	33	54	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	6.55.03.0	-	+++,90%
D4	34	60	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	4*4	-	+,40%
D5	35	58	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	5.54.02.0	+,1%	+,30%
D6	36	53	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	6.05.04.0	+,10%	++,80%
D7	37	57	M	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	4.5*3.5	-	+,40%
D8	38	41	F	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	*	+,3%	++,90%
D9	39	50	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	5*3	+,5%	++,100%
D10	40	50	M	Liver	Hepatocellular carcinoma	2	T2N0M0	II	Malignant	*	+,10%	+,10%
E1	41	47	M	Liver	Hepatocellular carcinoma with necrosis	2--3	T3N0M0	IIIA	Malignant	8.56.03.5	-	+,60%
E2	42	42	M	Liver	Hepatocellular carcinoma with necrosis	2--3	T2N0M0	II	Malignant	5.05.03.5	+,5%	+,60%
E3	43	57	M	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	1764	-	+,70%
E4	44	38	M	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	15.5124	+,10%	++,80%
E5	45	27	F	Liver	Hepatocellular carcinoma	3	T4N0M0	IIIB	Malignant	*	-	-
E6	46	63	M	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	6.55.03.5	-	++,90%
E7	47	51	M	Liver	Hepatocellular carcinoma	3	T3N0M0	IIIA	Malignant	*	++,30%	++,80%
E8	48	52	F	Liver	Hepatocellular carcinoma	3	T2N0M0	II	Malignant	6.04.54.5	+,25%	++,80%
E9	49	50	F	Liver	Cholangiocellular carcinoma	2	T3N1M0	IIIB	Malignant	5	+,1%	+++,100%
E10	50	62	M	Liver	Cholangiocellular carcinoma with necrosis	2--3	T2N0M0	II	Malignant	6	+,15%	++,100%
F1	51	60	F	Liver	Cholangiocellular carcinoma	2--3	T3N0M0	IIIA	Malignant	6*7	-	+,40%
F2	52	64	M	Liver	Cholangiocellular carcinoma with degeneration	3	T3N1M0	IIIB	Malignant	9	-	+,30%
F3	53	68	M	Liver	Cholangiocellular carcinoma	3	T3N0M0	IIIA	Malignant	5*4	++,40%	++,90%
F4	54	37	M	Liver	Cirrhosis of No.16	*	*	*	Cirrhosis	*	-	++,100%
F5	55	46	M	Liver	Cirrhosis	*	*	*	Cirrhosis	*	-	++,90%
F6	56	48	M	Liver	Cirrhosis	*	*	*	Cirrhosis	*	-	+,70%
F7	57	58	F	Liver	Cirrhosis (hepatocellular carcinoma)	*	*	*	Cirrhosis	*	-	++,90%
F8	58	24	M	Liver	Cirrhosis of No.29	*	*	*	Cirrhosis	*	-	++,90%
F9	59	69	M	Liver	Cirrhosis of No.4	*	*	*	Cirrhosis	*	-	+,40%
F10	60	45	M	Liver	Cirrhosis of No.14	*	*	*	Cirrhosis	*	-	++,70%
G1	61	58	M	Liver	Cirrhosis of No.35	*	*	*	Cirrhosis	*	-	++,80%
G2	62	62	M	Liver	Cirrhosis	*	*	*	Cirrhosis	*	-	++,90%
G3	63	53	F	Liver	Cirrhosis of No.36	*	*	*	Cirrhosis	*	+,5%	++,80%
G4	64	37	M	Liver	Cirrhosis (hyperplasia)	*	*	*	Cirrhosis	*	+,3%	++,80%
G5	65	62	M	Liver	Cirrhosis of No.26	*	*	*	Cirrhosis	*	-	+,30%
G6	66	53	M	Liver	Cirrhosis	*	*	*	Cirrhosis	*	+,1%	+,50%
G7	67	59	M	Liver	Cirrhosis	*	*	*	Cirrhosis	*	-	++,90%
G8	68	62	M	Liver	Cirrhosis of No.22	*	*	*	Cirrhosis	*	-	++,90%
G9	69	65	M	Liver	Cirrhosis	*	*	*	Cirrhosis	*	-	+,90%
G10	70	45	M	Liver	Cirrhosis of No.2	*	*	*	Cirrhosis	*	-	++,60%
H1	71	52	F	Liver	Cirrhosis	*	*	*	Cirrhosis	*	-	+,40%
H2	72	40	M	Liver	Cirrhosis of No.9	*	*	*	Cirrhosis	*	-	++,90%
H3	73	36	M	Liver	Cirrhosis	*	*	*	Cirrhosis	*	-	++,80%
H4	74	72	F	Liver	Cirrhosis of No.6	*	*	*	Cirrhosis	*	-	++,90%
H5	75	34	M	Liver	Cirrhosis	*	*	*	Cirrhosis	*	-	++,90%
H6	76	45	M	Liver	Adjacent normal liver tissue	*	*	*	NAT	*	-	+,80%
H7	77	48	M	Liver	Adjacent normal liver tissue of No.25	*	*	*	NAT	*	-	++,90%
H8	78	60	F	Liver	Adjacent normal liver tissue	*	*	*	NAT	*	-	+,70%
H9	79	63	M	Liver	Adjacent normal liver tissue of No.11	*	*	*	NAT	*	-	++,70%
H10	80	63	M	Liver	Adjacent normal liver tissue	*	*	*	NAT	*	-	++,100%
_marker_

Find overlapping cases with this tissue array:

DLV8014

File Format: .xlsx

Release Date: 2025-01-17 15:54:16
Download

	1	2	3	4	5	6	7	8	9	10
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

	1	2	3	4	5	6	7	8	9	10
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma

	1	2	3	4	5	6	7	8	9	10
A	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
B	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
C	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
F	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
G	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
H	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	_ma